Nicoya Lifesciences
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $28M
Investors
- 8
About Nicoya Lifesciences
Nicoya Lifesciences Inc., founded in 2012 in Kitchener, Canada, specializes in advanced biosensor technology. The company was co-founded by Paulo Simas and Ryan Denomme.Nicoya Lifesciences Inc. specializes in advanced biosensor technology, primarily offering its flagship products, the OpenSPR and Alto systems, which integrate surface plasmon resonance (SPR) technology with digital microfluidics. These instruments are designed for real-time, label-free analysis of biomolecular interactions, providing researchers with high-quality binding kinetics and affinity data directly on their benchtops. The company serves a diverse customer base, including over 600 research laboratories and academic institutions worldwide, particularly in the fields of drug discovery, antibody characterization, and vaccine development. Their products are utilized in various global markets, including North America, Europe, and Asia, focusing on institutions engaged in biochemistry, molecular biology, and related scientific research.Nicoya Lifesciences generates revenue through the sale of its specialized instruments and associated software solutions, structured primarily as direct-to-consumer transactions with research institutions and labs. The pricing mechanism involves one-time purchases of the OpenSPR and Alto systems, along with potential recurring revenue from software licenses and consumables required for ongoing experiments. The company’s transaction model includes options for clients to engage in subscription-based access to software updates and technical support services that enhance the functionality of their instruments.In December 2021, Nicoya Lifesciences Inc. The company plans to expand into new international markets, focusing on regions not previously targeted. This strategic development will seek to position Nicoya as a key player in the biosensor technology market.
Who invested in Nicoya Lifesciences
8 investors across 2 rounds
See all investors in Nicoya Lifesciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nicoya Lifesciences
Who invested in Nicoya Lifesciences?
Nicoya Lifesciences has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nicoya Lifesciences raised?
Nicoya Lifesciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nicoya Lifesciences last raise money?
Nicoya Lifesciences's most recent round on record is a Series A, in Dec 2021.
What does Nicoya Lifesciences do?
Nicoya Lifesciences is a biotechnology company.
Where is Nicoya Lifesciences headquartered?
Nicoya Lifesciences is headquartered in Kitchener, Canada.
Which VCs invest in companies like Nicoya Lifesciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nicoya Lifesciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nicoya Lifesciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.